Ｈｅａｒｔｓｅｅｄの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/22 | 2,173 | 2,193 | 2,114 | 2,136 | -72 | -3.3% | 616,400 |
| 2025/04/21 | 2,286 | 2,345 | 2,190 | 2,208 | -62 | -2.7% | 823,100 |
| 2025/04/18 | 2,299 | 2,433 | 2,250 | 2,270 | +48 | +2.2% | 1,610,900 |
| 2025/04/17 | 2,175 | 2,250 | 2,141 | 2,222 | +118 | +5.6% | 469,900 |
| 2025/04/16 | 2,161 | 2,203 | 2,104 | 2,104 | -106 | -4.8% | 507,400 |
| 2025/04/15 | 2,240 | 2,290 | 2,200 | 2,210 | +39 | +1.8% | 664,500 |
| 2025/04/14 | 2,336 | 2,405 | 2,144 | 2,171 | -186 | -7.9% | 1,053,400 |
| 2025/04/11 | 2,094 | 2,390 | 2,089 | 2,357 | +213 | +9.9% | 1,569,300 |
| 2025/04/10 | 2,130 | 2,158 | 2,011 | 2,144 | +154 | +7.7% | 1,029,700 |
| 2025/04/09 | 2,172 | 2,180 | 1,913 | 1,990 | +128 | +6.9% | 1,936,700 |
| 2025/04/08 | 1,800 | 1,890 | 1,779 | 1,862 | +251 | +15.6% | 616,700 |
| 2025/04/07 | 1,602 | 1,750 | 1,601 | 1,611 | -289 | -15.2% | 1,163,500 |
| 2025/04/04 | 2,026 | 2,055 | 1,811 | 1,900 | -148 | -7.2% | 1,106,000 |
| 2025/04/03 | 1,870 | 2,070 | 1,863 | 2,048 | +48 | +2.4% | 629,000 |
| 2025/04/02 | 2,000 | 2,056 | 1,992 | 2,000 | -5 | -0.2% | 393,600 |
| 2025/04/01 | 2,187 | 2,231 | 2,001 | 2,005 | -185 | -8.4% | 871,500 |
| 2025/03/31 | 2,236 | 2,303 | 2,166 | 2,190 | -35 | -1.6% | 699,800 |
| 2025/03/28 | 2,158 | 2,232 | 2,101 | 2,225 | +117 | +5.6% | 758,900 |
| 2025/03/27 | 2,130 | 2,195 | 2,053 | 2,108 | -61 | -2.8% | 833,500 |
| 2025/03/26 | 2,290 | 2,300 | 2,158 | 2,169 | -146 | -6.3% | 1,121,900 |
| 2025/03/25 | 2,400 | 2,406 | 2,280 | 2,315 | -35 | -1.5% | 884,200 |
| 2025/03/24 | 2,499 | 2,520 | 2,341 | 2,350 | +6 | +0.3% | 1,784,000 |
| 2025/03/21 | 2,156 | 2,398 | 2,156 | 2,344 | +190 | +8.8% | 1,941,500 |
| 2025/03/19 | 2,181 | 2,280 | 2,154 | 2,154 | -77 | -3.5% | 1,198,100 |
| 2025/03/18 | 2,301 | 2,455 | 2,207 | 2,231 | -91 | -3.9% | 3,239,000 |
| 2025/03/17 | 2,098 | 2,375 | 2,006 | 2,322 | +313 | +15.6% | 3,742,100 |
| 2025/03/14 | 1,820 | 2,145 | 1,819 | 2,009 | +254 | +14.5% | 4,097,700 |
| 2025/03/13 | 1,786 | 1,798 | 1,740 | 1,755 | -15 | -0.8% | 469,700 |
| 2025/03/12 | 1,760 | 1,781 | 1,731 | 1,770 | +20 | +1.1% | 438,600 |
| 2025/03/11 | 1,664 | 1,765 | 1,655 | 1,750 | +61 | +3.6% | 502,400 |
| 2025/03/10 | 1,670 | 1,759 | 1,660 | 1,689 | +30 | +1.8% | 553,400 |
| 2025/03/07 | 1,650 | 1,707 | 1,636 | 1,659 | -21 | -1.3% | 345,400 |
| 2025/03/06 | 1,681 | 1,708 | 1,669 | 1,680 | ±0 | ±0% | 247,600 |
| 2025/03/05 | 1,664 | 1,710 | 1,655 | 1,680 | -24 | -1.4% | 342,700 |
| 2025/03/04 | 1,782 | 1,790 | 1,689 | 1,704 | -118 | -6.5% | 680,300 |
| 2025/03/03 | 1,800 | 1,837 | 1,768 | 1,822 | +56 | +3.2% | 402,400 |
| 2025/02/28 | 1,805 | 1,836 | 1,734 | 1,766 | -74 | -4% | 445,000 |
| 2025/02/27 | 1,820 | 1,863 | 1,751 | 1,840 | +10 | +0.5% | 562,000 |
| 2025/02/26 | 1,856 | 1,868 | 1,798 | 1,830 | -29 | -1.6% | 393,200 |
| 2025/02/25 | 1,763 | 1,913 | 1,762 | 1,859 | +60 | +3.3% | 736,100 |
| 2025/02/21 | 1,824 | 1,831 | 1,773 | 1,799 | -56 | -3% | 595,400 |
| 2025/02/20 | 1,766 | 1,855 | 1,735 | 1,855 | +69 | +3.9% | 690,700 |
| 2025/02/19 | 1,867 | 1,877 | 1,770 | 1,786 | -81 | -4.3% | 866,200 |
| 2025/02/18 | 1,860 | 1,996 | 1,800 | 1,867 | +36 | +2% | 1,798,300 |
| 2025/02/17 | 1,800 | 1,947 | 1,766 | 1,831 | +65 | +3.7% | 1,727,800 |
| 2025/02/14 | 1,682 | 1,785 | 1,647 | 1,766 | +100 | +6% | 983,900 |
| 2025/02/13 | 1,617 | 1,710 | 1,610 | 1,666 | +89 | +5.6% | 1,002,200 |
| 2025/02/12 | 1,620 | 1,652 | 1,570 | 1,577 | -42 | -2.6% | 792,200 |
| 2025/02/10 | 1,629 | 1,673 | 1,606 | 1,619 | -9 | -0.6% | 586,400 |
| 2025/02/07 | 1,806 | 1,829 | 1,627 | 1,628 | -180 | -10% | 1,751,000 |
101～
150
件表示中 / 278件
類似銘柄と比較する
現在ご覧いただいている「ハートシード」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ハートシード | 346,000円 | +246.7% | - | 0.00% | 736.17倍 | 10.48倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| 杏林製薬 | 153,300円 | -2.4% | -52.3% | 3.72% | 18.34倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 99,800円 | +20.3% | - | 0.00% | 176.95倍 | 1.38倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 63,200円 | +14.3% | - | 3.16% | 25.69倍 | 1.64倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 238,500円 | +16.9% | +33.2% | 2.31% | 13.03倍 | 1.03倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
